Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300

Journal of Virology

Volumn 76, Issue 21, 2002, Pages 11042-11053

  Müller, Andreas ^a   Ritzkowsky, Andreas ^a   Steger, Gertrud ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

E2 PROTEIN; PROTEIN P300; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; EMBRYO; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; VIRUS GENE; VIRUS STRAIN; WART VIRUS;

ACETYLTRANSFERASES; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; GENE EXPRESSION REGULATION, VIRAL; HISTONE ACETYLTRANSFERASES; HUMANS; KERATINOCYTES; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0036838694     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.21.11042-11053.2002     Document Type: Article

References (70)

1. Asahara, H., B. Santoso, E. Guzman, K. Du, P. A. Cole, I. Davidson, and M. Montminy. 2001. Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol. Cell. Biol. 21:7892-7900.
2. Benson, J. D., and P. M. Howley. 1995. Amino-terminal domains of he bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation. J. Virol. 69:4364-4372.
3. Benson, J. D., R. Lawande, and P. M. Howley. 1997. Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins. J. Virol. 71:8041-8047.
4. Berg, M., and A. Stenlund. 1997. Functional interactions between papillomavirus E1 and E2 proteins. J. Virol. 71:3853-3863.
5. Boeckle, S., H. Pfister, and G. Steger. 2002. A new cellular factor recognizes E2 binding sites which mediate transcriptional repression by E2. Virology 293:103-117.
6. Breiding, D. E., F. Sverdrup, M. J. Grossel, N. Moscufo, W. Boonchai, and E. J. Androphy. 1997. Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol. Cell. Biol. 17:7208-7219.
7. Chen, H., R. J. Lin, R. L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M. L. Privalski, Y. Nakatani, and R. M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
8. Demeret, C., C. Desaintes, M. Yaniv, and F. Thierry. 1997. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol. 71:9343-9349.
9. Demeret, C., M. Yaniv, and F. Thierry. 1994. The E2 transcriptional repressor can compensate for SP1 activation of the human papillomavirus type 18 early promoter. J. Virol. 68:7075-7082.
10. Dong, G., T. R. Broker, and L. T. Chow. 1994. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J. Virol. 68:1115-1127.
11. Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869-884.
12. Enzenauer, C., G. Mengus, A.-C. Lavigne, I. Davidson, H. Pfister, and M. May. 1998. Interaction of human papiliomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex. Intervirology 41:80-90.
13. Ferguson, M. K., and M. R. Botchan. 1996. Genetic analysis of the activation domain of bovine papillomavirus protein E2: its foie role in transcription and replication. J. Virol. 70:4193-4199.
14. Fuchs, P. G., and H. Pfister. 1997. Molecular biology of HPV and mechanisms of keratinocyte transformation. CRC Press, Boca Raton, Fla.
15. Gillitzer, E., G. Chen, and A. Stenlund. 2000. Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding. EMBO J. 19:3069-3079.
16. Giri, I., and M. Yaniv. 1988. Structural and mutational analysis of E2 transactivating proteins of papillomaviruses reveals three distinct functional domains. EMBO J. 7:2823-2829.
17. Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606.
18. Ham, J., N. Dostatni, F. Arnos, and M. Yaniv. 1991. Several different upstream promoter elements can potentiate transactivation by the BPV-1 E2 protein. EMBO J. 10:2931-2940.
19. Ham, J., G. Steger, and M. Yaniv. 1994. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. EMBO J. 13:147-157.
20. Haugen, T. H., L. Turek, F. M. Mercurio, T. P. Cripe, B. J. Olson, R. D. Anderson, D. Seidl, M. Karin, and J. Schiller. 1988. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 transactivator require an N-terminal amphipathic helix-containing E2 domain. EMBO J. 7:4245-4253.
21. Heike, T., S. Miyatake, M. Yoshida, K.-i. Arai, and A. Naoka. 1989. Bovine papilloma virus encoded E2 protein activates lymphokine genes through DNA elements, distinct from the consensus motif, in the long control region of its own genome. EMBO J. 8:1411-1417.
22. Hoffmann, A., and R. G. Roeder. 1991. Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies. Nucleic Acids Res. 19:6337-6338.
23. Jackson, M. E., and M. S. Campo. 1995. Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region. J. Virol. 69:6038-6046.
24. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
25. Kingston, R. E., and G. J. Narlikar. 1999. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 13:2339-2352.
26. Kitabayashi, I., A. Yokoyama, K. Shimizu, and M. Ohki. 1998. Interaction and functional cooperation of the leukemia-associated factors AML-1 and p300 in myeloid cell differentiation. EMBO J. 17:2994-3004.
27. Kovelman, R., G. K. Bilter, E. Glezer, A. Y. Tsou, and M. S. Barbosa. 1996. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses. J. Virol. 70:7549-7560.
28. Lee, D., B. Lee, J. Kim, D. W. Kim, and J. Choe. 2000. cAMP response element binding protein-binding protein binds to human papillomavirus E2 protein and activates E2 dependent transcription. J. Biol. Chem. 275:7045-7051.
29. Lee, K. Y., T. R. Broker, and L. T. Chow. 1998. Transcription factor YY1 represses cell-free replication from human papillomavirus origins. J. Virol. 72:4911-4917.
30. Mal, A., M. Sturniolo, R. L. Schiltz., M. K. Ghosh, and M. L. Harter. 2001. A role for histone deacetylase HDACL in modulating the transcriptional activity of MoyD: inhibition of the myogenic program. EMBO J. 20:1739-1753.
31. Masterson, P. J., M. A. Stanley, A. P. Lewis, and M. A. Romanos. 1998. A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase a-primase p68 subunit. J. Virol. 72:7407-7419.
32. Merika, M., A. J. Williams, G. Chen, T. Collins, and D. Thanos. 1998. Recruitment of CBP/p300 by the IFNβ enhanceosome is required for synergistic activation of transcription. Mol. Cell 1:277-287.
33. Meyers, C., M. G. Frattini, and L. A. Laimins. 1994. Tissue culture techniques for the study of human papillomaviruses in stratified epithelia. Academic Press, Orlando, Fla.
34. Miller Rank, N., and P. F. Lambert. 1995. Bovine papillomavirus type I E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J. Virol. 69:6323-6334.
35. Mink, S., B. Haenig, and K.-H. Klempnauer. 1997. Interaction and functional collaboration of p300 and C/EBPβ. Mol. Cell. Biol. 17:6609-6617.
36. Missero, C., E. Calautti, R. Eckner, J. Chin, L. H. Tsai, D. M. Livingston, and G. P. Dotto. 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92:5451-5455.
37. Mohr, I. J., R. Clark, S. Sun, E. J. Androphy, P. MacPherson, and M. R. Botchan. 1990. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250:1694-1699.
38. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
39. Pajunk, H. S., C. May, H. Pfister, and P. G. Fuchs. 1997. Regulatory interactions of transcription factor YYI with control sequences of the E6 promoter of human papillomavirus type 8. J. Gen. Virol. 78:3287-3295.
40. Partanen, A., J. Motoyama, and C. C. Hui. 1999. Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embogenesis. Int. J. Dev. Biol. 43:487-494.
41. Patel, D., S.-M. Huang, L. A. Baglia, and D. J. McCance. 1999. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18:5061-5072.
42. Peng, Y.-C., D. E. Breiding, F. Sverdrup, J. Richard, and E. J. Androphy. 2000. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol. 74:5872-5879.
43. Prakash, S. S., S. R. Grossman, R. B. Pepinsky, L. A. Laimins, and E. J. Androphy. 1992. Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 trans-activator. Genes Dev. 6:105-116.
44. Purdie, K. J., C. J. Sexton, C. M. Proby, M. T. Glover, A. T. Williams, J. N. Stables, and 1. M. Leigh. 1993. Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res. 53:5328-5333.
45. Schmidt, H.-M., G. Steger, and H. Pfister. 1997. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1. J. Virol. 71:8029-8034.
46. Shikama, N., J. Lyon, and N. Thangue. 1997. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7:230-236.
47. Slepak, T. I., K. A. Webster, J. Zang, H. Prentice, A. O'Dowd, M. N. Hicks, and N. H. Bishopric. 2001. Control of cardiac-specific transcription by p300 through myocyte enhancer factor 2D. J. Biol. Chem. 276:7575-7585.
48. Spalholz, B. A., P. F. Lambert, C. L. Lee, and P. M. Howley. 1987. Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region. J. Virol. 61:2128-2137.
49. 2443 promoter. J. Virol. 65:743-753.
50. Spalholz, B. A., Y. C. Yang, and P. M. Howley. 1985. Transactivation of a bovine papillomavirus transcriptional regulatory element by the E2 gene product. Cell 42:183-191.
51. Spencer, T. E., G. Jenster, M. M. Burcin, C. D. Allis, J. Zhou, C. A. Mizzen, N. J. McKenna, S. A. Onate, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198.
52. Steger, G., and S. Corbach. 1997. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71:50-58.
53. Steger, G., C. Schnabel, and H.-M. Schmidt. 2002. The hinge region of the human papillomavirus type 8 E2 protein activates the human p21 WAF1/CIPI promoter via interaction with Spl. J. Gen. Virol. 83:503-510.
54. Stenlund, A., and M. R. Botchan. 1990. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor, Genes Dev. 4:123-136.
55. Stubenrauch, F., I. Leigh, and H. Pfister. 1996. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J. Virol. 70:119-126.
56. Stubenrauch, F., J. Malejczyk, P. G. Fuchs, and H. Pfister. 1992. Late promoter of human papillomavirus type 8 and its regulation. J. Virol. 66:3485-3493.
57. Stubenrauch, F., and H. Pfister. 1994. Low-affinity E2 binding site mediates downmodulation of E2 transactivation of the human papillomavirus pe type 8 late promoter. J. Virol. 68:6959-6966.
58. Tan, S. H., B. Gloss, and H.-U. Bernard. 1992. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Spl from a proximal promoter element. Nucleic Acids Res. 20:251-256.
59. Thierry, F., and P. Howley. 1991. Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol. 3:90-100.
60. Uesugi, M., O. Nyanguile, H. Lu, A. J. Levine, and G. L. Verdine. 1997. Induced alpha helix in the VP16 activation domain upon binding to human TAF. Science 277:1310-1313.
61. Ushikai, M., M. J. Lace, Y. Yamakawa, M. Kono, J. Anson, et al. 1994. transactivation by the full-length E2 protein of human papillomavirus type 16 and bovine papillomavirus type I in vitro and in vivo: cooperation with activation domains of cellular transcription factors. J. Virol. 68:6653-6666.
62. Vo, N., and R. H. Goodman. 2001. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276:13505-13508.
63. Xiao, J. H., i. Davidson, H. Matthes, J.-M. Garnier, and P. Chambon. 1991. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65:551-568.
64. Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with adenoviral oncoprotein E1A. Nature 382:319-324.
65. Yang, Y.-C., H. Okayama, and P. M. Howley. 1985. Bovine papillomavirus contains multiple transforming genes. Proc. Natl. Acad. Sci. USA 82:1030-1034.
66. Yao, J.-M., D. E. Breiding, and E. J. Androphy 1998. Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. J. Virol. 72:1013-1019.
67. Yao, T.-P., S. P. Oh, M. Fuchs, N.-D. Zhou, L.-E. Ch'ng, D. Newsome, R. T. Bronson, E. Li, D. M. Livingston, and R. Eckner. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.
68. Yao, Y.-L., W.-M. Yang, and E. Seto. 2001. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21:5979-5991.
69. Zimmermann, H., R. Degenkolbe, H.-U. Bernard, and M. J. O'Connor. 1999. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J. Virol. 73:6209-6219.
70. Zimmermann, H., C.-H. Koh, R. Degenkolbe, M. J. O'Connor, A. Müller, G. Steger, J. J. Chen, Y. Lui, E. J. Androphy, and H.-U. Bernard. 2000. Interaction with CBP/p300 enables the bovine papillomavirus type I E6 protein to downregulate CBP/p300 mediated transcativation by p53., J. Gen. Virol. 81:2617-2623.